Why Jasper Therapeutics Shares Are Popping Off Today
Jasper Therapeutics Inc (NASDAQ: JSPR) shares are trading higher by 13.21% to $1.80 Tuesday morning after the company announced development prioritization of briquilimab in chronic diseases and stem cell transplant for rare diseases.